Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Modified-release drug delivery technology / / edited by Michael J. Rathbone. [et al.]
| Modified-release drug delivery technology / / edited by Michael J. Rathbone. [et al.] |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | New York : , : Informa Healthcare, , 2008 |
| Descrizione fisica | 1 online resource (514 p.) |
| Disciplina | 615.19 |
| Altri autori (Persone) | RathboneMichael J. <1957-> |
| Collana | Drugs and the pharmaceutical sciences |
| Soggetto topico |
Controlled release technology
Controlled release preparations Drug delivery systems Pharmaceutical technology |
| ISBN |
0-429-14580-2
1-4200-4436-2 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Preface; Contents; Chapter 1. Patent and Other Intellectual Property Rights in Drug Delivery; Chapter 2. Intellectual Property Developments and Issues in India; Chapter 3. Parameter Claims at the European Patent Office; Chapter 4. Japan's Patent Issues Relating to Modified Drug Delivery Technology; Chapter 5. Oral Transmucosal Drug Delivery; Chapter 6. Pilocarpine Buccal Insert; Chapter 7. OraVescent Drug Delivery System: A Novel Technology for the Transmucosal Delivery of Drugs; Chapter 8. DentiPatch Development; Chapter 9. Medicated Chewing Gum
Chapter 10. The Oral PowderJect Device for Mucosal Drug DeliveryChapter 11. The PerioChipTM: A Biodegradable Device for the Controlled Delivery of Chlorhexidine in the Subgingival Environment; Chapter 12. Modified-Release Delivery Systems for Oral Use; Chapter 13. Advances in Cellulose Ether-Based Modified-Release Technologies; Chapter SQZgelTM; Chapter 15. Thiolated Polymers for Controlled Release; Chapter 16. Two Concepts, One Technology: Controlled-Release Solid Dispersions Using Melt Extrusion (Meltrex) Chapter 17. Threeform-Technology for Controlled Release of Amorphous Active Ingredient for Once-Daily AdministrationChapter 18. Floating Gastroretentive Capsule for Controlled Drug Delivery; Chapter 19. Thin Film Oral Dosage Forms; Chapter 21. Enhanced Gastroretentive Dosage Form with Minimal Food Effects: GIRESTM; Chapter 22. Advancing Gastrointestinal PermeationEnhancement Formulations intothe Clinic: GIPETTM; Chapter 23. The Micropump Technology; Chapter 24. A Novel Microparticle Technology for Tailored Drug Release in the Gastrointestinal Tract Chapter 25. Lipid Nanoparticles (SLN, NLC, LDC) for the Enhancement of Oral AbsorptionChapter 26. Colonic Drug Delivery; Chapter 27. Biopolymers and Colonic Delivery; Chapter 28. Enteric Coating for Colonic Delivery; Chapter 29. Programmed Drug Delivery Systems and the Colon; Chapter 30. PulsincapTM and Hydrophilic Sandwich Capsules: Innovative Time-Delayed Oral Drug Delivery Technologies; Chapter 31. Targeting the Colon Using COLALTM: A Novel Bacteria-Sensitive Drug Delivery System; Chapter 32. Development of the Egalet Technology Chapter 33. Regulatory Aspects in Modified-Release Drug DeliveryChapter 34. Regulatory Issues in the United States Relating to Modified-Release Drug Formulations; Chapter 35. Japanese Regulatory Issues on Modified-Release Drug Products; Chapter 36. Regulatory Aspects of Delivery Systems in the European Union; Chapter 37. Canadian Regulatory Requirements for Drug Approval; Chapter 38. Regulating Modified-Release Drug Delivery Technologies in Australia; Back Cover |
| Record Nr. | UNINA-9910800076803321 |
| New York : , : Informa Healthcare, , 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modified-release drug delivery technology . Volume 1 / / edited by Michael J. Rathbone ... [et al.]
| Modified-release drug delivery technology . Volume 1 / / edited by Michael J. Rathbone ... [et al.] |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | New York, : Informa Healthcare, c2008 |
| Descrizione fisica | 1 online resource (514 p.) |
| Disciplina | 615.19 |
| Altri autori (Persone) | RathboneMichael J. <1957-> |
| Collana | Drugs and the pharmaceutical sciences |
| Soggetto topico |
Controlled release technology
Controlled release preparations Drug delivery systems Pharmaceutical technology |
| ISBN |
0-429-14580-2
1-4200-4436-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Preface; Contents; Chapter 1. Patent and Other Intellectual Property Rights in Drug Delivery; Chapter 2. Intellectual Property Developments and Issues in India; Chapter 3. Parameter Claims at the European Patent Office; Chapter 4. Japan's Patent Issues Relating to Modified Drug Delivery Technology; Chapter 5. Oral Transmucosal Drug Delivery; Chapter 6. Pilocarpine Buccal Insert; Chapter 7. OraVescent Drug Delivery System: A Novel Technology for the Transmucosal Delivery of Drugs; Chapter 8. DentiPatch Development; Chapter 9. Medicated Chewing Gum
Chapter 10. The Oral PowderJect Device for Mucosal Drug DeliveryChapter 11. The PerioChipTM: A Biodegradable Device for the Controlled Delivery of Chlorhexidine in the Subgingival Environment; Chapter 12. Modified-Release Delivery Systems for Oral Use; Chapter 13. Advances in Cellulose Ether-Based Modified-Release Technologies; Chapter SQZgelTM; Chapter 15. Thiolated Polymers for Controlled Release; Chapter 16. Two Concepts, One Technology: Controlled-Release Solid Dispersions Using Melt Extrusion (Meltrex) Chapter 17. Threeform-Technology for Controlled Release of Amorphous Active Ingredient for Once-Daily AdministrationChapter 18. Floating Gastroretentive Capsule for Controlled Drug Delivery; Chapter 19. Thin Film Oral Dosage Forms; Chapter 21. Enhanced Gastroretentive Dosage Form with Minimal Food Effects: GIRESTM; Chapter 22. Advancing Gastrointestinal PermeationEnhancement Formulations intothe Clinic: GIPETTM; Chapter 23. The Micropump Technology; Chapter 24. A Novel Microparticle Technology for Tailored Drug Release in the Gastrointestinal Tract Chapter 25. Lipid Nanoparticles (SLN, NLC, LDC) for the Enhancement of Oral AbsorptionChapter 26. Colonic Drug Delivery; Chapter 27. Biopolymers and Colonic Delivery; Chapter 28. Enteric Coating for Colonic Delivery; Chapter 29. Programmed Drug Delivery Systems and the Colon; Chapter 30. PulsincapTM and Hydrophilic Sandwich Capsules: Innovative Time-Delayed Oral Drug Delivery Technologies; Chapter 31. Targeting the Colon Using COLALTM: A Novel Bacteria-Sensitive Drug Delivery System; Chapter 32. Development of the Egalet Technology Chapter 33. Regulatory Aspects in Modified-Release Drug DeliveryChapter 34. Regulatory Issues in the United States Relating to Modified-Release Drug Formulations; Chapter 35. Japanese Regulatory Issues on Modified-Release Drug Products; Chapter 36. Regulatory Aspects of Delivery Systems in the European Union; Chapter 37. Canadian Regulatory Requirements for Drug Approval; Chapter 38. Regulating Modified-Release Drug Delivery Technologies in Australia; Back Cover |
| Record Nr. | UNINA-9910807006703321 |
| New York, : Informa Healthcare, c2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Molecular biology in medicinal chemistry [[electronic resource] /] / edited by Th. Dingermann, D. Steinhilber and G. Folkers
| Molecular biology in medicinal chemistry [[electronic resource] /] / edited by Th. Dingermann, D. Steinhilber and G. Folkers |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH, 2004 |
| Descrizione fisica | 1 online resource (437 p.) |
| Disciplina | 615.19 |
| Altri autori (Persone) |
DingermannTheodor
FolkersGerd SteinhilberDieter <1959-> |
| Collana | Methods and principles in medicinal chemistry |
| Soggetto topico |
Chiral drugs
Genomics Molecular biology Molecular pharmacology Pharmacogenomics |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-52027-2
9786610520275 3-527-60518-5 3-527-60266-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Molecular Biology in Medicinal Chemistry; Contents; Preface; Foreword; Contributors; Part I Molecular Targets; 1 Cellular Assays in Drug Discovery; 1.1 Introduction; 1.1.1 Positioning Cellular Assays; 1.1.2 Impact on Drug Discovery; 1.1.3 Classification of Cellular Assays; 1.1.4 Progress in Tools and Technologies for Cellular Compound Profiling; 1.2 Membrane Proteins and Fast Cellular Responses; 1.2.1 Receptors; 1.2.1.1 FLIPR Technology for Detection of Intracellular Calcium Release; 1.2.1.2 Competitive Immunoassay for Detection of Intracellular cAMP
1.2.1.3 Enzyme Fragment Complementation (EFC) Technology1.2.2 Membrane Transport Proteins; 1.2.2.1 Ion Channels; 1.2.2.2 MDR Proteins; 1.3 Gene and Protein Expression Profiling in High-throughput Formats; 1.3.1 Reporter Gene Assays in Lead Finding; 1.3.2 Reporter Gene Assays in Lead Optimization; 1.4 Spatio-temporal Assays and Subpopulation Analysis; 1.4.1 Phosphorylation Stage-specific Antibodies; 1.4.2 Target-protein-specific Antibodies; 1.4.3 Protein-GFP Fusions; 1.4.4 Fluorescence Resonance Energy Transfer (FRET) 1.4.5 GPCR Activation using Bioluminescence Resonance Energy Transfer (BRET)1.4.6 Protein Fragment Complementation Assays (PCA); 1.5 Phenotypic Assays; 1.5.1 Proliferation/Respiration/Toxicity; 1.5.2 Apoptosis; 1.5.3 Differentiation; 1.5.4 Monitoring Cell Metabolism; 1.5.5 Other Phenotypic Assays; Acknowledgments; References; 2 Gene Knockout Models; 2.1 Introduction; 2.2 Gene Knockout Mice; 2.2.1 ES Cells; 2.2.2 Targeting Vector; 2.2.3 Selection of Recombinant ES Cells; 2.2.4 Injection of Recombinant ES Cells into Blastocysts and Blastocyst Transfer to Pseudopregnant Recipients 2.2.5 Chimeras and F1 and F2 Offspring2.3 Tissue-Specific Gene Expression; 2.3.1 Ligand-Activated CRE Recombinases; 2.3.2 The Tetracycline/Doxycycline-Inducible Expression System; 2.4 Transgenic Mice; 2.5 Targeted Gene Disruption in Drosophila; 2.6 Targeted Gene Knockdown in Zebrafish; 2.7 Targeted Caenorhabditis Elegans Deletion Strains; References; 3 Reporter Gene Assay Systems for the Investigation of G-protein-coupled Receptors; 3.1 Receptors and Cellular Communication; 3.1.1 Ion Channel-linked Receptors; 3.1.2 Enzyme-linked Cell-surface Receptors; 3.1.3 GPCRs 3.2 Affinity and Activity of GPCR Ligands3.3 The Role of Transcription Factors in Gene Expression; 3.3.1 CREB; 3.3.2 SRF; 3.3.3 STAT Proteins; 3.3.4 c-Jun; 3.3.5 NF-AT; 3.4 Reporter Genes; 3.4.1 CAT; 3.4.2 β-Gal; 3.4.3 β-Glucuronidase; 3.4.4 AP; 3.4.5 SEAP; 3.4.6 β-Lactamase; 3.4.7 Luciferase; 3.4.8 GFP; 3.5 Reporter Gene Assay Systems for the Investigation of GPCRs; 3.5.1 Application of Luciferase as a Reporter Gene; 3.5.2 Application of other Reporter Genes for the Investigation of GPCRs; References; 4 From the Human Genome to New Drugs: The Potential of Orphan G-protein-coupled Receptors 4.1 Introduction |
| Record Nr. | UNINA-9910146243903321 |
| Weinheim, : Wiley-VCH, 2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Molecular biology in medicinal chemistry [[electronic resource] /] / edited by Th. Dingermann, D. Steinhilber and G. Folkers
| Molecular biology in medicinal chemistry [[electronic resource] /] / edited by Th. Dingermann, D. Steinhilber and G. Folkers |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH, 2004 |
| Descrizione fisica | 1 online resource (437 p.) |
| Disciplina | 615.19 |
| Altri autori (Persone) |
DingermannTheodor
FolkersGerd SteinhilberDieter <1959-> |
| Collana | Methods and principles in medicinal chemistry |
| Soggetto topico |
Chiral drugs
Genomics Molecular biology Molecular pharmacology Pharmacogenomics |
| ISBN |
1-280-52027-2
9786610520275 3-527-60518-5 3-527-60266-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Molecular Biology in Medicinal Chemistry; Contents; Preface; Foreword; Contributors; Part I Molecular Targets; 1 Cellular Assays in Drug Discovery; 1.1 Introduction; 1.1.1 Positioning Cellular Assays; 1.1.2 Impact on Drug Discovery; 1.1.3 Classification of Cellular Assays; 1.1.4 Progress in Tools and Technologies for Cellular Compound Profiling; 1.2 Membrane Proteins and Fast Cellular Responses; 1.2.1 Receptors; 1.2.1.1 FLIPR Technology for Detection of Intracellular Calcium Release; 1.2.1.2 Competitive Immunoassay for Detection of Intracellular cAMP
1.2.1.3 Enzyme Fragment Complementation (EFC) Technology1.2.2 Membrane Transport Proteins; 1.2.2.1 Ion Channels; 1.2.2.2 MDR Proteins; 1.3 Gene and Protein Expression Profiling in High-throughput Formats; 1.3.1 Reporter Gene Assays in Lead Finding; 1.3.2 Reporter Gene Assays in Lead Optimization; 1.4 Spatio-temporal Assays and Subpopulation Analysis; 1.4.1 Phosphorylation Stage-specific Antibodies; 1.4.2 Target-protein-specific Antibodies; 1.4.3 Protein-GFP Fusions; 1.4.4 Fluorescence Resonance Energy Transfer (FRET) 1.4.5 GPCR Activation using Bioluminescence Resonance Energy Transfer (BRET)1.4.6 Protein Fragment Complementation Assays (PCA); 1.5 Phenotypic Assays; 1.5.1 Proliferation/Respiration/Toxicity; 1.5.2 Apoptosis; 1.5.3 Differentiation; 1.5.4 Monitoring Cell Metabolism; 1.5.5 Other Phenotypic Assays; Acknowledgments; References; 2 Gene Knockout Models; 2.1 Introduction; 2.2 Gene Knockout Mice; 2.2.1 ES Cells; 2.2.2 Targeting Vector; 2.2.3 Selection of Recombinant ES Cells; 2.2.4 Injection of Recombinant ES Cells into Blastocysts and Blastocyst Transfer to Pseudopregnant Recipients 2.2.5 Chimeras and F1 and F2 Offspring2.3 Tissue-Specific Gene Expression; 2.3.1 Ligand-Activated CRE Recombinases; 2.3.2 The Tetracycline/Doxycycline-Inducible Expression System; 2.4 Transgenic Mice; 2.5 Targeted Gene Disruption in Drosophila; 2.6 Targeted Gene Knockdown in Zebrafish; 2.7 Targeted Caenorhabditis Elegans Deletion Strains; References; 3 Reporter Gene Assay Systems for the Investigation of G-protein-coupled Receptors; 3.1 Receptors and Cellular Communication; 3.1.1 Ion Channel-linked Receptors; 3.1.2 Enzyme-linked Cell-surface Receptors; 3.1.3 GPCRs 3.2 Affinity and Activity of GPCR Ligands3.3 The Role of Transcription Factors in Gene Expression; 3.3.1 CREB; 3.3.2 SRF; 3.3.3 STAT Proteins; 3.3.4 c-Jun; 3.3.5 NF-AT; 3.4 Reporter Genes; 3.4.1 CAT; 3.4.2 β-Gal; 3.4.3 β-Glucuronidase; 3.4.4 AP; 3.4.5 SEAP; 3.4.6 β-Lactamase; 3.4.7 Luciferase; 3.4.8 GFP; 3.5 Reporter Gene Assay Systems for the Investigation of GPCRs; 3.5.1 Application of Luciferase as a Reporter Gene; 3.5.2 Application of other Reporter Genes for the Investigation of GPCRs; References; 4 From the Human Genome to New Drugs: The Potential of Orphan G-protein-coupled Receptors 4.1 Introduction |
| Record Nr. | UNINA-9910830570303321 |
| Weinheim, : Wiley-VCH, 2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Molecular biology in medicinal chemistry / / edited by Th. Dingermann, D. Steinhilber and G. Folkers
| Molecular biology in medicinal chemistry / / edited by Th. Dingermann, D. Steinhilber and G. Folkers |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH, 2004 |
| Descrizione fisica | 1 online resource (437 p.) |
| Disciplina | 615.19 |
| Altri autori (Persone) |
DingermannTheodor
FolkersGerd SteinhilberDieter <1959-> |
| Collana | Methods and principles in medicinal chemistry |
| Soggetto topico |
Chiral drugs
Genomics Molecular biology Molecular pharmacology Pharmacogenomics |
| ISBN |
1-280-52027-2
9786610520275 3-527-60518-5 3-527-60266-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Molecular Biology in Medicinal Chemistry; Contents; Preface; Foreword; Contributors; Part I Molecular Targets; 1 Cellular Assays in Drug Discovery; 1.1 Introduction; 1.1.1 Positioning Cellular Assays; 1.1.2 Impact on Drug Discovery; 1.1.3 Classification of Cellular Assays; 1.1.4 Progress in Tools and Technologies for Cellular Compound Profiling; 1.2 Membrane Proteins and Fast Cellular Responses; 1.2.1 Receptors; 1.2.1.1 FLIPR Technology for Detection of Intracellular Calcium Release; 1.2.1.2 Competitive Immunoassay for Detection of Intracellular cAMP
1.2.1.3 Enzyme Fragment Complementation (EFC) Technology1.2.2 Membrane Transport Proteins; 1.2.2.1 Ion Channels; 1.2.2.2 MDR Proteins; 1.3 Gene and Protein Expression Profiling in High-throughput Formats; 1.3.1 Reporter Gene Assays in Lead Finding; 1.3.2 Reporter Gene Assays in Lead Optimization; 1.4 Spatio-temporal Assays and Subpopulation Analysis; 1.4.1 Phosphorylation Stage-specific Antibodies; 1.4.2 Target-protein-specific Antibodies; 1.4.3 Protein-GFP Fusions; 1.4.4 Fluorescence Resonance Energy Transfer (FRET) 1.4.5 GPCR Activation using Bioluminescence Resonance Energy Transfer (BRET)1.4.6 Protein Fragment Complementation Assays (PCA); 1.5 Phenotypic Assays; 1.5.1 Proliferation/Respiration/Toxicity; 1.5.2 Apoptosis; 1.5.3 Differentiation; 1.5.4 Monitoring Cell Metabolism; 1.5.5 Other Phenotypic Assays; Acknowledgments; References; 2 Gene Knockout Models; 2.1 Introduction; 2.2 Gene Knockout Mice; 2.2.1 ES Cells; 2.2.2 Targeting Vector; 2.2.3 Selection of Recombinant ES Cells; 2.2.4 Injection of Recombinant ES Cells into Blastocysts and Blastocyst Transfer to Pseudopregnant Recipients 2.2.5 Chimeras and F1 and F2 Offspring2.3 Tissue-Specific Gene Expression; 2.3.1 Ligand-Activated CRE Recombinases; 2.3.2 The Tetracycline/Doxycycline-Inducible Expression System; 2.4 Transgenic Mice; 2.5 Targeted Gene Disruption in Drosophila; 2.6 Targeted Gene Knockdown in Zebrafish; 2.7 Targeted Caenorhabditis Elegans Deletion Strains; References; 3 Reporter Gene Assay Systems for the Investigation of G-protein-coupled Receptors; 3.1 Receptors and Cellular Communication; 3.1.1 Ion Channel-linked Receptors; 3.1.2 Enzyme-linked Cell-surface Receptors; 3.1.3 GPCRs 3.2 Affinity and Activity of GPCR Ligands3.3 The Role of Transcription Factors in Gene Expression; 3.3.1 CREB; 3.3.2 SRF; 3.3.3 STAT Proteins; 3.3.4 c-Jun; 3.3.5 NF-AT; 3.4 Reporter Genes; 3.4.1 CAT; 3.4.2 β-Gal; 3.4.3 β-Glucuronidase; 3.4.4 AP; 3.4.5 SEAP; 3.4.6 β-Lactamase; 3.4.7 Luciferase; 3.4.8 GFP; 3.5 Reporter Gene Assay Systems for the Investigation of GPCRs; 3.5.1 Application of Luciferase as a Reporter Gene; 3.5.2 Application of other Reporter Genes for the Investigation of GPCRs; References; 4 From the Human Genome to New Drugs: The Potential of Orphan G-protein-coupled Receptors 4.1 Introduction |
| Record Nr. | UNINA-9910877222403321 |
| Weinheim, : Wiley-VCH, 2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Molecular descriptors for chemoinformatics [[electronic resource] /] / Roberto Todeschini and Viviana Consonni
| Molecular descriptors for chemoinformatics [[electronic resource] /] / Roberto Todeschini and Viviana Consonni |
| Autore | Todeschini Roberto |
| Edizione | [2nd ed., rev. and enl.] |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH |
| Descrizione fisica | 1 online resource (1264 p.) |
| Disciplina | 615.19 |
| Altri autori (Persone) | ConsonniViviana |
| Collana | Methods and principles in medicinal chemistry |
| Soggetto topico |
Cheminformatics
Drugs - Design Molecular pharmacology |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-282-38002-8
9786612380020 3-527-62876-2 3-527-62877-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Molecular Descriptors for Chemoinformatics; Volume I; Dedication; Contents; The Authors; Acknowledgments; Preface; A Personal Foreword; Introduction; Historical Perspective; QSAR/QSPR Modeling; How to Learn From This Book; User's Guide; Notations and Symbols; Alphabetical Listing; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; Q; R; S; T; U; V; W; X; Y; Z; Greek Alphabet Entries; Numerical Entries; Volume 2; Bibliography; Appendix A: Greek alphabets; Appendix B: Acronyms; Appendix C: Molecular structures |
| Record Nr. | UNINA-9910139506003321 |
Todeschini Roberto
|
||
| Weinheim, : Wiley-VCH | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Molecular descriptors for chemoinformatics [[electronic resource] /] / Roberto Todeschini and Viviana Consonni
| Molecular descriptors for chemoinformatics [[electronic resource] /] / Roberto Todeschini and Viviana Consonni |
| Autore | Todeschini Roberto |
| Edizione | [2nd ed., rev. and enl.] |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH |
| Descrizione fisica | 1 online resource (1264 p.) |
| Disciplina | 615.19 |
| Altri autori (Persone) | ConsonniViviana |
| Collana | Methods and principles in medicinal chemistry |
| Soggetto topico |
Cheminformatics
Drugs - Design Molecular pharmacology |
| ISBN |
1-282-38002-8
9786612380020 3-527-62876-2 3-527-62877-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Molecular Descriptors for Chemoinformatics; Volume I; Dedication; Contents; The Authors; Acknowledgments; Preface; A Personal Foreword; Introduction; Historical Perspective; QSAR/QSPR Modeling; How to Learn From This Book; User's Guide; Notations and Symbols; Alphabetical Listing; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; Q; R; S; T; U; V; W; X; Y; Z; Greek Alphabet Entries; Numerical Entries; Volume 2; Bibliography; Appendix A: Greek alphabets; Appendix B: Acronyms; Appendix C: Molecular structures |
| Record Nr. | UNINA-9910830627503321 |
|
Todeschini Roberto
|
||
| Weinheim, : Wiley-VCH | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Molecular descriptors for chemoinformatics / / Roberto Todeschini and Viviana Consonni
| Molecular descriptors for chemoinformatics / / Roberto Todeschini and Viviana Consonni |
| Autore | Todeschini Roberto |
| Edizione | [2nd ed., rev. and enl.] |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH |
| Descrizione fisica | 1 online resource (1264 p.) |
| Disciplina | 615.19 |
| Altri autori (Persone) | ConsonniViviana |
| Collana | Methods and principles in medicinal chemistry |
| Soggetto topico |
Cheminformatics
Drugs - Design Molecular pharmacology |
| ISBN |
1-282-38002-8
9786612380020 3-527-62876-2 3-527-62877-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Molecular Descriptors for Chemoinformatics; Volume I; Dedication; Contents; The Authors; Acknowledgments; Preface; A Personal Foreword; Introduction; Historical Perspective; QSAR/QSPR Modeling; How to Learn From This Book; User's Guide; Notations and Symbols; Alphabetical Listing; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; Q; R; S; T; U; V; W; X; Y; Z; Greek Alphabet Entries; Numerical Entries; Volume 2; Bibliography; Appendix A: Greek alphabets; Appendix B: Acronyms; Appendix C: Molecular structures |
| Record Nr. | UNINA-9910877592503321 |
|
Todeschini Roberto
|
||
| Weinheim, : Wiley-VCH | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Molecular Docking : Recent Advances / / edited by Erman Salih İstifli
| Molecular Docking : Recent Advances / / edited by Erman Salih İstifli |
| Pubbl/distr/stampa | London : , : IntechOpen, , 2023 |
| Descrizione fisica | 1 online resource (xiii, 182 pages) : illustrations |
| Disciplina | 615.19 |
| Collana | Biomedical engineering, |
| Soggetto topico | Pharmaceutical biotechnology |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Introductory Chapter: Molecular Docking-The Transition from the Micro Nature of Small Molecules to the Macro World -- 2. Fundamentals of Molecular Docking and Comparative Analysis of Protein-Small-Molecule Docking Approaches -- 3. Molecular Docking: Metamorphosis in Drug Discovery -- 4. Molecular Docking in the Study of Ligand-Protein Recognition: An Overview -- 5. Development of Nucleic Acid Targeting Molecules: Molecular Docking Approaches and Recent Advances -- 6. Repurposing Drugs as Potential Therapeutics for the SARS-Cov-2 Viral Infection: Automatizing a Blind Molecular Docking High-throughput Pipeline -- 7. N1-(3-(Trifluoromethyl)Phenyl) Isophthalamide Derivatives as Promising Inhibitors of Vascular Endothelial Growth Factor Receptor: Pharmacophore-Based Design, Docking, and MM-PBSA/MM-GBSA Binding Energy Estimation. |
| Altri titoli varianti | Molecular Docking |
| Record Nr. | UNINA-9910647495203321 |
| London : , : IntechOpen, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Molecular docking / / edited by Dimitrios Vlachakis
| Molecular docking / / edited by Dimitrios Vlachakis |
| Pubbl/distr/stampa | London, England : , : IntechOpen, , [2018] |
| Descrizione fisica | 1 online resource (188 pages) : illustrations |
| Disciplina | 615.19 |
| Soggetto topico | Pharmaceutical technology |
| ISBN |
1-83881-432-9
1-78923-355-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910317808103321 |
| London, England : , : IntechOpen, , [2018] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
